Targeted morphoproteomic profiling of Ewing's sarcoma treated with insulin-like growth factor 1 receptor (IGF1R) inhibitors: response/resistance signatures.

by Vivek Subbiah, Aung Naing, Robert E Brown, Helen Chen, Laurence Doyle, Patricia LoRusso, Robert Benjamin, Pete Anderson, Razelle Kurzrock
Published 2011-04-01